Verition Fund Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-2,147
Closed -$239K 1430
2018
Q1
$239K Buy
+2,147
New +$241K 0.02% 926
2017
Q1
Sell
-5,415
Closed -$426K 1555
2016
Q4
$426K Buy
+5,415
New +$421K 0.04% 632
2016
Q3
Sell
-3,202
Closed -$220K 1361
2016
Q2
$220K Buy
+3,202
New +$221K 0.03% 729

Other funds holding CMD

Verition Fund Management's CMD Position: Q2 2018 in Review

Verition Fund Management sold out of Cantel Medical Corporation (CMD) in Q2 2018, closing a stake of 2,147 shares — an estimated $239K sold.

Verition Fund Management first reported a position in CMD in Q2 2016 and held it in 3 quarters. The position peaked at $426K in Q4 2016. 292 funds tracked by Wall St. Rank hold CMD as of Q2 2018.

  • Verition Fund Management reported no remaining Cantel Medical Corporation position as of Q2 2018 after selling out during the quarter.
  • Verition Fund Management sold 2,147 Cantel Medical Corporation shares in Q2 2018, an estimated $239K.
  • Verition Fund Management first reported a position in Cantel Medical Corporation in Q2 2016 and held it in 3 quarters.
  • Verition Fund Management's Cantel Medical Corporation position peaked at $426K in Q4 2016.
  • 292 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2018.

Based on Verition Fund Management's 13F filing for Q2 2018, filed 15 Aug 2018.